Hayward, CA, United States of America

Flavius Martin

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2008-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Flavius Martin: Innovator in Rheumatoid Arthritis Treatment

Introduction

Flavius Martin is a notable inventor based in Hayward, CA, who has made significant contributions to the field of medical research, particularly in the treatment and diagnosis of rheumatoid arthritis. With a total of 6 patents to his name, Martin's work has the potential to impact the lives of many individuals suffering from this chronic condition.

Latest Patents

Among his latest patents, Martin has developed methods for treating, diagnosing, and monitoring rheumatoid arthritis. These innovative methods include identifying effective therapeutic agents and predicting patient responsiveness to these treatments. Additionally, he has created methods and compositions related to B cell assays, which involve measuring serum BAFF levels to monitor B cell levels in subjects, thereby aiding in the treatment of various diseases.

Career Highlights

Throughout his career, Flavius Martin has worked with prominent companies in the biotechnology sector, including Genentech, Inc. and Biogen Idec. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Martin's notable coworkers include Glynn Dennis, Jr. and Michael Townsend. Their collaborative efforts have further advanced the research and development of innovative treatments for rheumatoid arthritis.

Conclusion

Flavius Martin's contributions to the field of rheumatoid arthritis treatment exemplify the importance of innovation in medical research. His patents and collaborations reflect a commitment to improving patient outcomes and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…